Literature DB >> 12357263

Osteoporosis: trends and intervention.

Angela M Inzerillo1, Mone Zaidi.   

Abstract

Osteoporosis is a skeletal disorder in which bone strength is compromised due to loss of bone density and bone quality. It is the leading cause of serious morbidity and functional loss in the elderly. At times, it is difficult for the clinician to distinguish between the disease and normal skeletal aging, but advances in the scientific understanding of the underlying disease process have made management of osteoporosis a preventable disease for the most part. Defining the point at which these age-related skeletal changes require intervention presents a major challenge to researchers and clinicians alike. There are several reasons for these difficulties. There is a long period of bone loss before the onset of clinically apparent disease. Also current diagnostic procedures have been shown to distinguish those at risk of fracture and those not at risk, there is a large overlap in bone density between persons who experience fractures and those who do not. Research efforts directed at these issues have increased dramatically, as have developing technologies in the measurement and screening of bone mineral density. Ongoing advances in the therapeutic modalities have promoted new methods to treat this disorder. The foregoing review will describe the mechanisms responsible for osteoporosis and the modalities used to screen and diagnose this common disorder. Various therapeutic approaches now in use, and some promising experimental trials, will be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12357263

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  7 in total

1.  Osteogenic potentials with joint-loading modality.

Authors:  Hiroki Yokota; Shigeo M Tanaka
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

2.  Influence of bone marrow composition on measurements of trabecular microstructure using decay due to diffusion in the internal field MRI: simulations and clinical studies.

Authors:  Sara M Sprinkhuizen; Jerome L Ackerman; Yi-Qiao Song
Journal:  Magn Reson Med       Date:  2013-12-31       Impact factor: 4.668

3.  Positive associations of bone mineral density with body mass index, physical activity, and blood triglyceride level in men over 70 years old: a TCVGHAGE study.

Authors:  Yih-Jing Tang; Wayne Huey-Herng Sheu; Pi-Haw Liu; Wen-Jane Lee; Ying-Tsung Chen
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

4.  Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures.

Authors:  Takuya Ohtomo; Mariko Uehara; José Luis Peñalvo; Herman Adlercreutz; Shin-ichi Katsumata; Kazuharu Suzuki; Ken Takeda; Ritsuko Masuyama; Yoshiko Ishimi
Journal:  Eur J Nutr       Date:  2008-07-11       Impact factor: 5.614

5.  Are individuals with severe haemophilia A prone to reduced bone density?

Authors:  Hassan Mansouritorghabeh; Zahra Rezaieyazdi; Zahra Badiei
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

6.  Isoflavone metabolism and bone-sparing effects of daidzein-metabolites.

Authors:  Mariko Uehara
Journal:  J Clin Biochem Nutr       Date:  2013-05-01       Impact factor: 3.114

7.  Histomorphometry of the organic matrix of the femur in ovariectomized rats treated with sodium alendronate.

Authors:  Patricia Tanios Haddad; Márcio Salazar; Luzmarina Hernandes
Journal:  Rev Bras Ortop       Date:  2014-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.